HomeSGX-LISTED COMPANIESHG Metal Manufacturing Limited: Half-Year 2025 Financial Report

HG Metal Manufacturing Limited: Half-Year 2025 Financial Report

Published on

spot_img

HG Metal Manufacturing Limited experienced a period of increased revenue driven by a substantial rise in sales volume, even as average selling prices for steel products continued to decline. The Group’s financial results were shaped by changes in operating expenses, finance costs, and the absence of a previously discontinued operation. Facing persistent market pressures, the company is adjusting its strategies to maintain competitiveness and profitability.

• The Group’s sales volume saw a significant uplift, helping to bolster overall revenue despite ongoing price reductions in the steel market
• A major factor in the financial reporting was the completion of a divestment, removing a segment that had previously incurred losses
• Management is actively enhancing inventory controls and pursuing operational efficiencies to navigate volatile market dynamics and secure margins

Latest articles

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...

More like this

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...